Key result
Compound 43, an FPR1/FPR2 agonist, improved left ventricular ejection fraction and reduced adverse remodeling and scarring compared with vehicle in animal models post-myocardial infarction.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zaman et al. (2019) conducted an editorial in Myocardial Infarction. Compound 43 (Cmpd43) vs. Vehicle was evaluated. Compound 43, an FPR1/FPR2 agonist, improved left ventricular ejection fraction and reduced adverse remodeling and scarring compared with vehicle in animal models post-myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: